Preview
Unable to display preview. Download preview PDF.
Références
Antonarakis SE, McKusick VA (2000) OMIM passes the 1 000-disease-gene mark. Nat Genet 25: 11
Barth JH, Layton AM and Cunliffe WJ (1996) Endocrine factors in pre-and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 134: 1057–9
Bennett RE, Wilke WS and Murphy DP (1983) Spondyloarthropathy and hidradenitis suppurativa. Ann Intern Med 98: 112
Bleck O, McGrath JA and South AP (2001) Searching for candidate genes in the new millenium. Exp Dermatol 26: 279–83
Bohm M and Luger TA (1998) The pilosebaceous unit is part of the skin immune system. Dermatology 196: 75–9
Bolland S and Ravetch JV (2000) Spontaneous autoimmune disease in FcgRIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277–85
Bonifas JM, Morley BJ, Oakey RE, Kan YW and Epstein Jr EH (1987) Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. Proc Nat Acad Sci USA 84: 9248–51
Botstein D and Risch N (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet 33: 228–237
Brenneman DE, Phillips TM, Hauser J, Hill JM, Spong CY and Gozes I (2003) Complex array of cytokines released by vasoactive intestinal peptide. Neuropeptides 37 2
Brunsting HA (1952) Hidradenitis and other variants of acne (1952) AMA Arch Derm Syphilol 65(3): 303–15
Burrows NP, and Jones RR (1992) Crohn’s disease in association with hidradenitis suppurativa. Br J Dermatol 126: 523
Cohen J (1985) Arthritis occurring with hidradenitis suppurativa. J Rheumatol 12: 1208–9
Consortium. MGS (2002) Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520–62
Delgado M, Abad C, Martinez C, Leceta J and Gomariz RP (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nature Med 7: 563–8
Delgado M, and Ganea D (2003) Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J
Donis-Keller H, Green P, Helms C et al. (1987) A genetic linkage map of the human genome. Cell 51: 319–37
Eady EA, and Cove JH (2000) Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment. Am J Clin Dermatol 1: 201–9
Fitzsimmons JS, Fitzsimmons EM, Guilbert PR (1984) Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet 21: 281–5
Fitzsimmons JS, Guilbert PR (1985) A family study of hidradenitis suppurativa. J Med Genet 22: 367–73
Fitzsimmons JS, Guilbert PR, Fitzsimmons EM (1985) Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113: 1–8
Goischke HK and Ochsendorf FR (2001) Acne inversa in Crohn’s disease. Z Gastroenterol 39: 965–9
Gold SC, Delaney TJ (1974) Familial acne conglobata, hidradenitis suppurativa, pili torti and cataracts. Br J Dermatol 91(10): 54–7
Gomariz RP, Martinez C, Abad C, Leceta J and Delgado M (2001) Immunology of VIP: a review and therapeutical perspectives. Curr Pharm Des 7: 89–111
Guy R and Kealey T (1998) The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol 110: 410–5
Harrison BJ, Read GF and Hughes LE (1988) Endocrine basis for the clinical presentation of hidradenitis suppurativa. Br J Surg 75: 972–5
Hellmann DB (1992) Spondyloarthropathy with hidradenitis suppurativa. Jama 267: 2363–5
Hernanz A, Medina S, de Miguel E and Martin-Mola E (2003) Effect of calcitonin gene-related peptide, neuropeptide Y, substance P and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regul Pept 115: 19–24
Jemec GB, and Gniadecka M (1997b) Ultrasound examination of hair follicles in hidradenitis suppurativa. Arch Dermatol 133: 967–70
Jeremy AHT, Holland DB, Roberts SG, Thomson KF and Cunliffe WJ (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121: 20–7
Kakurai M, Fujita N, Murata S, Furukawa Y, Demitsu T and Nakagawa H (2001) Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Invest Dermatol 116: 743–9
Kang S, Cho S, Chung JH et al. (2005) Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acnes lesions in vivo. Am J Pathol 166(6): 1691–9
Katsanos KH, Christodoulou DK and Tsianos EV (2002) Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol 97: 2155–6
Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136: 896–907
Klinge CM (2001) Estrogen receptor interaction with estrogen response elements. Nuc Acid Res 29: 2905–19
Knaggs HE, Holland DB, Morris C, Wood EJ and Cunliffe WJ (1994) Quantification of cellular proliferation in acne using the monoclonal antibody Ki67. J Invest Dermatol 102: 89–92
Knaysi GA, Cosman B, Crikelair GF (1968) Hidradenitis suppurativa. JAMA 203(1): 73–6
Laval SH, Timms A, Edwards S et al. (2001) Wholegenome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 68: 918–26
Lee YA, Ruschendorf F, Windemuth C et al. (2000) Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am J Hum Genet 67: 1020–4
Maquat LE (2001) The power of point mutations. Nature Genetics 27: 5–6
Martinez F, Nos P, Benlloch S and Ponce J (2001) Hidradenitis suppurativa and Crohn’s disease: response to treatment with infliximab. Inflamm Bowel Dis 7: 323–6
McGrath JA (2004) Translational benefits from research on rare genodermatoses. Australas J Dermatol 45: 89–93
Mengesha YM, Holcombe TC and Hansen RC (1999) Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol 16: 292–6
Mullis K, Faloona F, Scharf S et al. (1986) Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Col Spr Harb Symp Quant Biol 11: 263–73
Oh HS, and Smart RC (1996) An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Nat Acad Sci USA 93: 12525–30
Ott VL, Tamir I, Niki M, Pandolfi PP and Cambier JC (2002) Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signalling. J Immunol 168: 4430–9
Pagani F, Buratti E, Stuani C et al. (2002) A new type of mutation causes a splicing defect in ATM. Nature Genet 30: 426–9
Rioux JD, Silverberg MS, Daly MJ et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66: 1863–70
Rosner IA, Burg CG, Wisnieski JJ et al. (1993) The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 20: 684–7
Rosner IA, Richter DE, Huettner TL et al. (1982) Spondyloarthropathy associated with hidradenitis suppurativa and acne conglobata. Ann Intern Med 97: 520–5
Roy MK, Appleton MA, Delicata RJ et al. (1997) Probable association between hidradenitis suppurativa and Crohn’s disease: significance of epithelioid granuloma. Br J Surg 84: 375–6
Spurr NK, Young BD and Bryant SP (1998) ICRF Handbook of Genome Analysis, Blackwell Science Ltd, Oxford
Strachan T and Reid AP (1999) Human Molecular Genetics 2. 2nd edn, BIOS Scientific Publishers Ltd., Oxford
Takai T, Ono M, Hikida M et al. (1996) Augmented humoral and anaphylactic responses in Fc gamma RIIdeficient mice. Nature 379: 346–9
Terwilliger JD and Ott J (1994) Handbook of human genetic linkage. 1st edn, The John Hopkins University Press, London
Thornton MJ (2002) Biological effects of estrogens on the skin. Exp Dermatol 11: 487–502
Thornton MJ, Taylor AH, Mulligan K et al. (2003) The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc 8: 100–3
Tsianos EV, Dalekos GN, Tzermias C et al. (1995) Hidradenitis suppurativa in Crohn’s disease. A further support to this association. J Clin Gastroenterol 20: 151–3
Venter JC et al. (2001) The sequence of the human genome. Science 291: 1304–51
Victor FC and Gottlieb AB (2002) TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis. J Drugs Dermatol 1: 264–75
von der Werth JM and Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14: 389–92
von der Werth JM, Williams HC, Raeburn JA (2000) The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 142: 947–53
Walter P, Green S, Greene G et al. (1985) Cloning of the human estrogen receptor cDNA. Proc Nat Acad Sci USA 82: 7889–93
Weber JL and May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 338–96
Wood P (2003) Molecular genetic analysis of inherited epidermal disorders. Thesis submitted for the Degree of Doctor of Philosophy, Molecular and Cellular Pathology, University of Dundee
Worton RG, Thompson MW (1988) Genetics of Duchenne muscular dystrophy. Annu Rev Genet 22: 601–29
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag France, Paris,
About this chapter
Cite this chapter
von der Werth, J., Wood, P., Irvine, A.D., McLean, W.H.I. (2008). La génétique de l’hidradénite suppurée. In: Hidradénite suppurée. Springer, Paris. https://doi.org/10.1007/978-2-287-72063-5_10
Download citation
DOI: https://doi.org/10.1007/978-2-287-72063-5_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-72062-8
Online ISBN: 978-2-287-72063-5